» Articles » PMID: 24797527

Superhydrophobic Nitric Oxide-releasing Xerogels

Overview
Journal Acta Biomater
Publisher Elsevier
Date 2014 May 7
PMID 24797527
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Superhydrophobic nitric oxide (NO)-releasing xerogels were prepared by spray-coating a fluorinated silane/silica composite onto N-diazeniumdiolate NO donor-modified xerogels. The thickness of the superhydrophobic layer was used to extend NO release durations from 59 to 105h. The resulting xerogels were stable, maintaining superhydrophobicity for up to 1month (the longest duration tested) when immersed in solution, with no leaching of silica or undesirable fragmentation detected. The combination of superhydrophobicity and NO release reduced viable Pseudomonas aeruginosa adhesion by >2-logs. The killing effect of NO was demonstrated at longer bacterial contact times, with superhydrophobic NO-releasing xerogels resulting in 3.8-log reductions in adhered viable bacteria vs. controls. With no observed toxicity to L929 murine fibroblasts, NO-releasing superhydrophobic membranes may be valuable antibacterial coatings for implants as they both reduce adhesion and kill bacteria that do adhere.

Citing Articles

Investigation of the susceptibility of clinical infection loads to nitric oxide antibacterial treatment.

Estes Bright L, Mondal A, Pinon V, Kumar A, Thompson S, Brisbois E Nitric Oxide. 2024; 154():19-28.

PMID: 39561942 PMC: 11729576. DOI: 10.1016/j.niox.2024.11.003.


Bioinspired superhydrophobic surfaces with silver and nitric oxide-releasing capabilities to prevent device-associated infections and thrombosis.

Ozkan E, Estes Bright L, Kumar A, Pandey R, Devine R, Francis D J Colloid Interface Sci. 2024; 664:928-937.

PMID: 38503078 PMC: 11025530. DOI: 10.1016/j.jcis.2024.03.082.


Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications.

Andrabi S, Sharma N, Karan A, Shahriar S, Cordon B, Ma B Adv Sci (Weinh). 2023; 10(30):e2303259.

PMID: 37632708 PMC: 10602574. DOI: 10.1002/advs.202303259.


Antibacterial gas therapy: Strategies, advances, and prospects.

Wang T, Zhu X, Wu F Bioact Mater. 2022; 23:129-155.

PMID: 36406249 PMC: 9661653. DOI: 10.1016/j.bioactmat.2022.10.008.


Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Kim J, Thomas S Pharmacol Rev. 2022; 74(4):1146-1175.

PMID: 36180108 PMC: 9553106. DOI: 10.1124/pharmrev.121.000500.